DSM-Firmenich stock gets new bio-based resin capacity in France
Published on 11/10/2026 at 10:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResin expansion adds industrial capacity
- dsm-firmenich commissioned the French unit during the first half of 2026 and is now ramping up production.
- The facility serves adhesives, coatings, paints and chewing gum markets across Europe, North America and Asia.
- Third-quarter like-for-like sales growth reached 5%, while the company lifted its full-year 2026 outlook to around 5%.
dsm-firmenich announced on Monday, November 9, 2026, that production is ramping up at a new hydrogenated bio-based resins unit in Vielle-Saint-Girons in southwestern France. The company said the facility, commissioned during the first half of 2026, produces ingredients for industrial applications including adhesives, coatings, paints and chewing gum.
The announcement came from dsm-firmenich in a company release. The unit belongs to DRT Industry Ingredients and uses pine-based rosin to make highly hydrogenated resins. dsm-firmenich said the products are intended for customers in Europe, North America and Asia.
New plant broadens resin reach
The facility will produce the DRT Foral and Staybelite product lines. The company said the additional capacity supports applications in electronics, automotive products, road signage, coatings, paints and chewing gum. The manufacturing process is designed to deliver low color and stability across significant temperature changes and demanding climatic conditions.
Amaury Roquette, Executive Vice President Ingredients, Perfumery & Beauty, said the investment strengthens the company's capabilities in high-end rosin resins. Loïc Mourey, Vice President Sales DRT Industry Ingredients, said the facility would expand commercialization of the two hydrogenated rosin resin ranges.
The site is fully automated. More than 50 companies, 90% of them local, contributed to construction, alongside 120 equipment suppliers. The plant holds ISO 50001 certification and FSSC 22000 certification for chewing-gum resin production. dsm-firmenich also said more than 90% of the site's co-products are valorized.
Growth outlook remains elevated
The French expansion follows dsm-firmenich's November 4 trading update. In its quarterly release, the group reported third-quarter continuing-operations sales of 2,368 million euros, compared with 2,238 million euros a year earlier. Like-for-like sales growth was 5%, driven by volume, while adjusted EBITDA rose on a like-for-like basis and the margin reached 20.4%.
Management raised the full-year 2026 like-for-like sales-growth outlook to around 5% from the previous range of 2% to 4%. The company kept its adjusted EBITDA margin expectation at around 20% and its adjusted gross operating free cash flow-to-sales target at 11% to 12%. CEO Dimitri de Vreeze said business conditions entering the fourth quarter remained supportive, with a healthy innovation pipeline and high win rates.
Stock trades lower in morning dealing
DSM-Firmenich stock traded at 104.83 euros on Lang & Schwarz at 10:10 CET on Tuesday, November 10, 2026. The quote provides a current trading reference while the company's latest operating news points to added capacity and a higher sales-growth target.
DSM-Firmenich stock facts
- Company: dsm-firmenich AG
- ISIN: CH1216478797
- Share price: 104.83 euros on Lang & Schwarz at 10:10 CET on November 10, 2026
- Primary listings: Euronext Amsterdam and SIX Swiss Exchange
- Q3 2026 like-for-like sales growth: 5%
- FY 2026 like-for-like sales-growth outlook: around 5%
The broader Swiss market can be followed through the current market reports for the SMI.
